Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Co-trimoxazole may help treat autoimmune diseases.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

EPF can occur without visible pustules.

A man with severe leprosy developed painless ulcers and numbness, treated successfully with multiple drugs and vitamins.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Overexpressing the glucocorticoid receptor in mice leads to abnormal skin development and reduced inflammation.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Interface dermatitis is the most common skin change in drug-induced hypersensitivity syndrome.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.